Story thread · 2 reports / 2 sources
BridgeBio Oncology Therapeutics (BBOT) Bets Big On A Narrower KRAS Playbook
finance.yahoo.com · 3d
First report: BridgeBio Oncology slides as it tightens the scope of its KRAS program — endpts.com, 4d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.